Skip to main content

Table 2 Proportion of patients, PCPs, and specialists who report each symptom as “Very” or “Extremely” disruptive

From: A patient and physician survey of fibromyalgia across Latin America and Europe

  Patients (%) PCPs (%)a Specialists (%)a
Common symptoms Latin America (N = 300) Europe (N = 600) Latin America (N = 253) Europe (N = 503) Latin America (N = 254) Europe (N = 495)
Chronic/Widespread pain 86%*‡ 78% 79% 78% 80% 79%
Problems sleeping 80%ठ76%ठ70%* 50% 69%* 55%
Fatigue 80%ठ75%ठ69% 67% 66% 69%
Headaches 69%ठ77%*ठ52%* 37% 45% 38%
Facial pain 59%‡§ 69%*‡§ 40%*† 24% 30% 27%
Heightened sensitivity to touch 61%‡§ 72%*‡§ 50%* 42% 48% 49%†
Difficulty concentrating 73%ठ73%ठ51%* 36% 50%* 39%
Numbness &/or tingling sensations 59%‡§ 62%‡§ 48%*† 25% 37%* 24%
Feelings of anxiety 75%*ठ64%ठ66%* 44% 64%* 47%
Feelings of depression 73% 77%ठ74%* 58% 73%* 62%
Joint pain 80%‡§ 76%‡§ 68%*† 55% 54% 53%
Stiffness 74%‡§ 74%‡§ 59%*† 39% 44% 39%
Leg cramps 67%*ठ60%ठ42%* 24% 35%* 27%
Low back pain 81%*‡§ 75%‡§ 59%*† 44% 50% 45%
  1. a Base case: Physicians currently seeing or have seen patients with FM; * = P < 0.05 Europe vs. Latin America within group (Patient, PCP, Specialist); † P < 0.05 PCP vs. specialist (within region); ‡ P < 0.05 patient vs. PCP (within region); § P < 0.05 patient vs. specialist (within region).